ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 728317 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 728317; 2) Community: the network communities that were significantly associated with the response to NSC 728317; 3) Molecule: the relationships between components within communities and NSC 728317; 4) MDR: the compounds that were significantly associated with the NSC 728317.

NSC Compound Enrichment Correlation
NSC 154948 M-AMSA 0.00741876119839022 0.43988096
NSC 300289 Pinafide 0.00741876119839022 0.41816742
NSC 303812 Aphidicoline glycinate 0.00741876119839022 0.5204013
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.00741876119839022 0.091416561
NSC 603071 Aminocamptothecin 0.00741876119839022 0.3493913
NSC 651605 Null 0.00741876119839022 0.51637941
NSC 678040 Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- 0.00741876119839022 0.30323099
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.00741876119839022 0.18590026
NSC 681633 Camptothecin Derivative 0.00741876119839022 0.44134298
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.00741876119839022 0.25980977
Total:116  Current:25    [First] [Prev] [Next] [Last]